Connect your AI

Chemours CC Payments Of Debt Issuance Costs

Payments Of Debt Issuance Costs at other companies

IngevityNGVT

——

Calumet, Inc.CLMT

——

Other financials

Income statement

Revenue$1.4B+1.0%

Gross profit$212.0M-10.2%

Net income-$29.0M-480%

EPS (diluted)-$0.19-533%

Balance sheet

Cash & equivalents$563.0M+21.3%

Total debt$4.4B0.0%

Total equity$215.0M-62.0%

Total assets$7.3B-1.5%

Cash flow

Operating cash flow-$44.0M+60.7%

CapEx$49.0M-41.7%

Free cash flow-$93.0M+52.6%

Valuation

Market cap$3B+63.6%

Profitability

Gross margin15.1%-3.8pp

Net margin-7%-7.3pp

FCF margin5.1%-1.7pp

Returns & leverage

Return on equity-105%-107pp

Debt / equity20.6×+12.8×

Current ratio1.8×+0.1×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfDebtIssuanceCosts.

The official record: Chemours’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemours's payments of debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Chemours's payments of debt issuance costs?: Chemours (CC) reported payments of debt issuance costs of $10M in Q1 2026.